Arthritis with Aloe

Product NDC: 59779-499
11-digit product format: 597790499
Labeler code: 59779
Product ID: 59779-499_54994477-0fd4-43b3-ab33-0eb406e0e412
Type: HUMAN OTC DRUG
Nonproprietary name: Trolamine Salicylate 10%
Dosage form: CREAM
Route: TOPICAL
Labeler: CVS
Application: part348
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2014-12-16
Marketing end: 0000-00-00
Substance: TROLAMINE SALICYLATE
Active strength: 10 g/100g
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	59779-499		I	Inactivated by FDA	2026-08-11
excluded package	package	59779-499	59779-499-03	I	Inactivated by FDA	2026-08-11
excluded package	package	59779-499	59779-499-05	I	Inactivated by FDA	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 63 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59779-499-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59779-499-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59779-499-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59779-499-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59779-499-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59779-499-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59779-499-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59779-499-03	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59779-499-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59779-499-03	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59779-499-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59779-499-03	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59779-499-05	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59779-499-03	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59779-499-05	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59779-499-03	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59779-499-05	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59779-499-03	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59779-499-05	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59779-499-03	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59779-499-05	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59779-499-03	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59779-499-05	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59779-499-03	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	59779-499-05	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	59779-499-03	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	59779-499-05	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	59779-499-03	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	59779-499-05	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	59779-499-03	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	59779-499-05	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	59779-499-03	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	59779-499-05	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	59779-499-03	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	59779-499-05	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	59779-499-03	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	59779-499-05	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	59779-499-03	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	59779-499-05	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	59779-499-03	`e2bbac7714bc…`	`27bdfed8d636…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
59779-499-03	2020-01-31	C162847	48780-1	9d75b9d0-c8e3-f424-e053-dadaa90a57ce	Drug Facts
59779-499-05	2020-01-31	C162847	48780-1	9d75b9d0-c8e3-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
59779-499-03	Arthritis with AloeCVS	85 g in 1 TUBE	CREAM	85	1
59779-499-03	Arthritis with AloeCVS	1 in 1 CARTON	CREAM	1	1
59779-499-05	Arthritis with AloeCVS	142 g in 1 TUBE	CREAM	142	1
59779-499-05	Arthritis with AloeCVS	1 in 1 CARTON	CREAM	1	1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
TROLAMINE SALICYLATE	ACTIVE INGREDIENT	H8O4040BHD	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Cetyl Alcohol	INACTIVE INGREDIENT	936JST6JCN	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Mineral Oil	INACTIVE INGREDIENT	T5L8T28FGP	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
POTASSIUM PHOSPHATE, UNSPECIFIED FORM	INACTIVE INGREDIENT	B7862WZ632	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Stearic Acid	INACTIVE INGREDIENT	4ELV7Z65AP	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1
Water	INACTIVE INGREDIENT	059QF0KO0R	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
59779-499	ARTHRITIS WITH ALOE CVS (TROLAMINE SALICYLATE 10%) CREAM [CVS]	1	Legacy NDC, 4 package rows	20150421_f0f94ab7-7466-4434-81da-1a89a7755cf1.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
H8O4040BHD	TROLAMINE SALICYLATE	2174-16-5	TROLAMINE SALICYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313518	trolamine salicylate 10 % Topical Cream	PSN	f0f94ab7-7466-4434-81da-1a89a7755cf1	1
313518	trolamine salicylate 100 MG/ML Topical Cream	SCD	f0f94ab7-7466-4434-81da-1a89a7755cf1	1
313518	trolamine salicylate 10 % Topical Cream	SY	f0f94ab7-7466-4434-81da-1a89a7755cf1	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Status
59779-499-03	59779049903	85 g in 1 TUBE	85 g	Historical
59779-499-05	59779049905	142 g in 1 TUBE	142 g	Historical